Promotions & Moves

Entera Bio Appoints Chief Executive Officer

Gridley is a highly accomplished pharmaceutical executive with proven business development and financial acumen

Entera Bio Ltd. announced the appointment of Adam Gridley as Chief Executive Officer, effective immediately. Phillip Schwartz, Ph.D., former CEO of Entera since the Company’s inception in 2010, will continue with the Company as President of Research & Development and Executive Vice President at Entera.   Prior to Entera, Mr. Gridley was President, CEO, and a Director of Histogenics Corporation where he led the company’s $70 million IPO in December 2014, subsequently raising over $50 millio...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters